Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H1 2012 (Related Reports)

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H1 2012


March 19, 2012
210 Pages - SKU: GMD3811121
License type:
Online Download      US $500.00
Global Site License      US $1,500.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018
4/14/2014 | published by: MarketsandMarkets
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018 The global cell analysis market  |  read more...
$4,650.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
4/14/2014 | published by: GBI Research
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth Summary The leading business intelligence provider GBI Research has released its latest research report,  |  read more...
$3,500.00
Conference Documentation: Asthma & COPD
4/2/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Asthma & COPD SMi proudly present their 10th annual Asthma and COPD conference taking place in Central London on Wednesday 2nd and Thursday 3rd April, 2014.  This year’s event will focus  |  read more...
$788.78
Urinary Tract Infections - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Urinary Tract Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Urinary Tract Infections - Pipeline Review, H1 2014’, provides an overview of the Urinary Tract Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Dyskinesia - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Dyskinesia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H1 2014’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dyskinesia, complete with comparative  |  read more...
$2,000.00
Oral Mucositis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Oral Mucositis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Oral Mucositis - Pipeline Review, H1 2014’, provides an overview of the Oral Mucositis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oral  |  read more...
$2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Actinic (Solar) Keratosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Actinic (Solar) Keratosis - Pipeline Review, H1 2014’, provides an overview of the Actinic (Solar) Keratosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014’, provides an overview of the Acute Respiratory Distress Syndrome’s therapeutic pipeline. This report provides comprehensive information  |  read more...
$2,000.00